SparkMaster 2: New software automates analysis of calcium release events

A team of UC Davis and University of Oxford researchers have developed an innovative tool: SparkMaster 2.

Left in limbo: When pharma halts rare disease research – Pharmaceutical Technology

When pharma companies pull out of gene therapy programmes, nonprofit organisations are taking matters into their own hands. Credit: afry_harvy via Shutterstock. The development of

July 3, 2024

Beacon Biosignals receives FDA clearance for sleep tracking headband

Dive Brief: Beacon Biosignals received U.S. Food and Drug Administration clearance for its sleep monitoring headband. Beacon’s at-home device, the Dreem 3S, features six electroencephalogram (EEG)

September 18, 2023

Clinical trial of three-month TB treatment regimen closed due to high rate of unfavorable outcomes

The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.